September 1st 2023
Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
Does stimulant medication for pediatric ADHD affect adult height?
November 8th 2022A recent review found that multiple clinical trials indicated a reduction in adult height potential for children with long-term use of stimulant medication for treatment of ADHD, but other studies conflict with this data.
Do preschool children with ADHD get the behavioral therapy they need?
April 24th 2022At the 2022 Pediatric Academic Societies meeting, Shruti Mittal, MD, FAAP, looked at how many children with attention-deficit/hyperactivity disorder get started on behavioral therapy before medication in the preschool years.
FDA approves Dyanavel XR for ADHD treatment in kids 6 and older
November 5th 2021In a clinical study of healthy adults, Dyanavel XR tablets were deemed to be bioequivalent to amphetamine extended-release oral suspension in patients with attention-deficit/hyperactivity disorder (ADHD) by the US Food and Drug Administration (FDA).
Prenatal exposure to analgesic opioid linked with elevated risk of ADHD
October 5th 2021A study has found that prenatal analgesic opioid exposure of 5 or more weeks is associated with a slightly elevated risk of attention-deficit/hyperactivity disorder (ADHD) in children compared to exposure of 4 weeks or less.